GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BT-200 | BT200
Compound class:
Nucleic acid
Comment: Rondaptivon pegol (BT200) belongs to the aptamer class of nucleic acid drugs/ligands. It binds to the A1 (platelet, heparin and collagen binding) domain of von Willebrand factor (vWF) [3]. Blocking interaction with receptors on platelets reduces platelet-mediated thrombogenesis [2]. Aptamer binding also prolongs the plasma half-life of factor VIII (FVIII) , which is mediated by interaction with the vWF D'/D3 domain, so offers potential in the treatment of FVIII deficiency hemophilia (hemophilia A) [1].
We have been unable to locate a full chemical SMILES for the ligand, or its HELM notation. |
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | Aptamer |
| Target | on Willebrand factor (VWF) A1 domain |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12620 | rondaptivon pegol |
Synonyms ![]() |
| BT-200 | BT200 |
Database Links ![]() |
|
| CAS Registry No. | 2573048-75-4 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL5314642 |
| DrugBank Ligand | DB18333 |
| GtoPdb PubChem SID | 504705460 |
| Search PubMed clinical trials | rondaptivon pegol |
| Search PubMed titles | rondaptivon pegol |
| Search PubMed titles/abstracts | rondaptivon pegol |